Total Payments
$18,209
2024 Payments
$3,204
Companies
66
Transactions
936
Medicare Patients
6,584
Medicare Billing
$892,110
Payment Breakdown by Category
Food & Beverage$18,186 (99.9%)
Education$22.52 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,186 | 932 | 99.9% |
| Education | $22.52 | 4 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,427 | 132 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,949 | 89 | $0 (2024) |
| Amgen Inc. | $1,753 | 96 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $896.01 | 54 | $0 (2024) |
| Novo Nordisk Inc | $895.63 | 52 | $0 (2024) |
| PFIZER INC. | $722.66 | 54 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $716.19 | 34 | $0 (2024) |
| GlaxoSmithKline, LLC. | $708.20 | 33 | $0 (2024) |
| Lilly USA, LLC | $697.16 | 36 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $515.94 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,204 | 143 | ABBVIE INC. ($548.23) |
| 2023 | $3,474 | 183 | ABBVIE INC. ($678.41) |
| 2022 | $2,841 | 143 | ABBVIE INC. ($420.86) |
| 2021 | $3,149 | 154 | AbbVie Inc. ($597.59) |
| 2020 | $1,287 | 66 | Allergan, Inc. ($187.14) |
| 2019 | $1,612 | 94 | AstraZeneca Pharmaceuticals LP ($217.39) |
| 2018 | $1,693 | 107 | Amgen Inc. ($322.27) |
| 2017 | $949.28 | 46 | Allergan Inc. ($179.30) |
All Payment Transactions
936 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Inflammation | ||||||
| 12/16/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Insomnia | ||||||
| 12/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Cardio-renal | ||||||
| 12/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Inflammation | ||||||
| 12/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: ANTI-ANXIETY | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Gastroenterology | ||||||
| 11/27/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Diabetes Care | ||||||
| 11/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: Cardio-renal | ||||||
| 11/26/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $9.95 | General |
| Category: Inflammation | ||||||
| 11/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Inflammation | ||||||
| 11/18/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Diabetes Care | ||||||
| 11/06/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/02/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $30.74 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $30.87 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/28/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Cardio-renal | ||||||
| 10/28/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: DERMATOLOGY | ||||||
| 10/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: RESPIRATORY | ||||||
| 10/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: Diabetes | ||||||
| 10/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: Inflammation | ||||||
| 10/08/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: ANTI-ANXIETY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 2,491 | 8,520 | $960,943 | $429,657 |
| 2022 | 23 | 1,962 | 3,764 | $461,647 | $215,607 |
| 2021 | 17 | 1,301 | 2,525 | $330,970 | $160,787 |
| 2020 | 12 | 830 | 1,291 | $202,306 | $86,059 |
Total Patients
6,584
Total Services
16,100
Medicare Billing
$892,110
Procedure Codes
74
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 530 | 1,418 | $248,284 | $130,934 | 52.7% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 131 | 1,530 | $130,050 | $51,015 | 39.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 180 | 1,146 | $121,020 | $47,474 | 39.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 352 | 684 | $85,595 | $46,902 | 54.8% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 143 | 1,005 | $121,845 | $44,174 | 36.3% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 66 | 647 | $64,700 | $26,480 | 40.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 67 | 451 | $60,885 | $24,061 | 39.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 63 | 76 | $28,500 | $18,091 | 63.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 85 | 85 | $20,874 | $10,067 | 48.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 349 | 674 | $9,845 | $5,662 | 57.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 66 | 96 | $16,925 | $4,169 | 24.6% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 62 | 108 | $16,400 | $3,692 | 22.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 16 | 17 | $4,675 | $2,931 | 62.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 19 | 19 | $3,357 | $2,667 | 79.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 64 | 64 | $2,880 | $2,139 | 74.3% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 66 | 66 | $3,300 | $2,090 | 63.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 13 | $4,066 | $2,006 | 49.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 44 | 157 | $6,160 | $1,671 | 27.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 24 | 24 | $3,840 | $1,520 | 39.6% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 59 | 60 | $2,595 | $1,009 | 38.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 58 | 66 | $2,298 | $797.58 | 34.7% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 35 | 114 | $2,850 | $108.42 | 3.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 440 | 1,058 | $185,150 | $94,487 | 51.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 278 | 522 | $65,250 | $35,805 | 54.9% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 89 | 275 | $34,375 | $14,058 | 40.9% |
About Dr. Gregor Paronian, M.D
Dr. Gregor Paronian, M.D is a Internal Medicine healthcare provider based in Pasadena, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/02/2008. The National Provider Identifier (NPI) number assigned to this provider is 1366627945.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregor Paronian, M.D has received a total of $18,209 in payments from pharmaceutical and medical device companies, with $3,204 received in 2024. These payments were reported across 936 transactions from 66 companies. The most common payment nature is "Food and Beverage" ($18,186).
As a Medicare-enrolled provider, Paronian has provided services to 6,584 Medicare beneficiaries, totaling 16,100 services with total Medicare billing of $892,110. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Pasadena, CA
- Active Since 01/02/2008
- Last Updated 07/31/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1366627945
Products in Payments
- FARXIGA (Drug) $1,368
- VRAYLAR (Drug) $1,352
- Otezla (Drug) $1,290
- Kerendia (Drug) $716.19
- UBRELVY (Drug) $677.79
- TRINTELLIX (Drug) $620.41
- TRELEGY ELLIPTA (Drug) $599.65
- REXULTI (Drug) $585.25
- JARDIANCE (Drug) $585.15
- Vascepa (Drug) $464.05
- ENTRESTO (Drug) $442.85
- ELIQUIS (Drug) $433.94
- XIFAXAN (Drug) $413.15
- Ozempic (Drug) $391.73
- BREZTRI (Drug) $390.28
- Repatha (Biological) $364.78
- Livalo (Drug) $287.39
- APLENZIN (Drug) $275.24
- LOREEV XR (Drug) $273.80
- NEXLETOL (Drug) $270.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Pasadena
Dr. Yuan Yuan, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $523,801
Internal Medicine $523,801
Christopher Dagher, M.d, M.D
Internal Medicine — Payments: $103,615
Internal Medicine $103,615
Peter Haddad, M.d, M.D
Internal Medicine — Payments: $87,600
Internal Medicine $87,600
Dr. Andrew Williams, M.d, M.D
Internal Medicine — Payments: $85,273
Internal Medicine $85,273
Joseph Dellinger, Md, MD
Internal Medicine — Payments: $77,175
Internal Medicine $77,175
Dr. Helen Moon, M.d, M.D
Internal Medicine — Payments: $61,882
Internal Medicine $61,882